The European Commission has cleared the proposed acquisition by Schering-Plough Corporation of Organon BS, a Dutch subsidiary of Akzo Nobel active in human and animal health. The Commission found that the notified transaction raised competition concerns in 12 veterinary product areas and more than 30 relevant national markets. Schering-Plough therefore proposed to divest the overlapping activities in all the markets where serious doubts were raised. In the light of these commitments, the Commission has concluded that the proposed transaction would not significantly impede effective competition in the European Economic Area.